Back to
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
MCRB
Showing 4 of 27 quarters
Position history for
CHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in SERES THERAPEUTICS INC
As of its Q1 2025 13F, Charles Schwab Investment Management held 834,107 shares of MCRB (Seres Therapeutics), worth $583,958. Charles Schwab Investment Management's 13F filings listed MCRB from Q4 2018 to Q1 2025, 26 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$708,362
Total Shares Change
-748,718
Quarter-by-Quarter History